OBJECTIVES: The objective of this study was to describe the offer and accessibility of vaccination services for adolescents and adults so they can be adapted to needs in the future. METHODS: A descriptive cross-sectional study was carried out among the 81 medical clinics that offer vaccination services in a region of Québec. RESULTS: The response was 70% (57/81). Over 90% of clinics planned to maintain or increase their offer of vaccination services over the next 5 years. One quarter of clinics did not have the facilities to optimize the cold chain respect. The principal barriers were the cost of purchasing vaccines and the low level of remuneration for vaccination. CONCLUSIONS: This study provided better knowledge of the actual and future offer and accessibility of vaccination for adolescents and adults in Québec. It was shown that evidence-based interventions known to improve vaccine storage and accessibility were absent in many medical clinics. (c) 2009 Elsevier Ltd. All rights reserved.
OBJECTIVES: The objective of this study was to describe the offer and accessibility of vaccination services for adolescents and adults so they can be adapted to needs in the future. METHODS: A descriptive cross-sectional study was carried out among the 81 medical clinics that offer vaccination services in a region of Québec. RESULTS: The response was 70% (57/81). Over 90% of clinics planned to maintain or increase their offer of vaccination services over the next 5 years. One quarter of clinics did not have the facilities to optimize the cold chain respect. The principal barriers were the cost of purchasing vaccines and the low level of remuneration for vaccination. CONCLUSIONS: This study provided better knowledge of the actual and future offer and accessibility of vaccination for adolescents and adults in Québec. It was shown that evidence-based interventions known to improve vaccine storage and accessibility were absent in many medical clinics. (c) 2009 Elsevier Ltd. All rights reserved.
Authors: D MacDougall; B A Halperin; J Isenor; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin Journal: Hum Vaccin Immunother Date: 2016-03-03 Impact factor: 3.452
Authors: D MacDougall; B A Halperin; D MacKinnon-Cameron; L Li; S A McNeil; J M Langley; S A Halperin Journal: Hum Vaccin Immunother Date: 2015-06-19 Impact factor: 3.452
Authors: D M MacDougall; B A Halperin; D MacKinnon-Cameron; Li Li; S A McNeil; J M Langley; S A Halperin Journal: BMJ Open Date: 2015-09-29 Impact factor: 2.692